EDBT 2026 Demo / reviewers in the wild / expert
Michael Fernández
dblp:93/1607
· DBLP profile ↗
3ranked-venue papers
2as first author
0since 2021 · last 2020
0000-0003-2273-733XORCID · corroborated
Domains — the database's venue-derived domains; a paper can count in several
Applied, interdisciplinary, general and emerging computing · 3 · 2 first-authorHuman-computer interaction and ubiquitous computing · 1 · 1 first-author
Expertise — from the expertise taxonomy: the topics of the expert's papers under the CCF categories. A weight counts papers with recency: 1 for a paper about the topic, 0.3 when the topic is its context, halved every five years.
| Interdisciplinary, comprehensive, and emerging computing
1 paper |
Bioinformatics and computational biology · 91% Medical and health informatics · 9% |
Topics — the 4 heaviest of 5, each with the papers that count most for it
| Topic | Weight | Papers | Last | Evidence papers |
|---|---|---|---|---|
Bioinformatics and computational biology › molecular informatics › cheminformatics
chemogenomics |
0.4 | 1 | 2020 | DeepCOP: deep learning-based approach to predict gene regulating effects of small molecules · Bioinform. 2020 |
Bioinformatics and computational biology › drug discovery
computational drug discovery |
0.4 | 1 | 2020 | DeepCOP: deep learning-based approach to predict gene regulating effects of small molecules · Bioinform. 2020 |
Bioinformatics and computational biology › drug discovery
drug screening |
0.4 | 1 | 2020 | DeepCOP: deep learning-based approach to predict gene regulating effects of small molecules · Bioinform. 2020 |
Medical and health informatics › precision medicine
precision oncology |
0.1 | 1 | 2020 | DeepCOP: deep learning-based approach to predict gene regulating effects of small molecules · Bioinform. 2020 |
Methods — techniques the papers use, named apart from their topics
molecular fingerprint · 0.4gene ontology descriptors · 0.4deep neural network · 0.4
| Year | Publication | Venue | Position |
|---|---|---|---|
| 2020 | DeepCOP: deep learning-based approach to predict gene regulating effects of small moleculesabstractMOTIVATION: Recent advances in the areas of bioinformatics and chemogenomics are poised to accelerate the discovery of small molecule regulators of cell development. Combining large genomics and molecular data sources with powerful deep learning techniques has the potential to revolutionize predictive biology. In this study, we present Deep gene COmpound Profiler (DeepCOP), a deep learning based model that can predict gene regulating effects of low-molecular weight compounds. This model can be used for direct identification of a drug candidate causing a desired gene expression response, without utilizing any information on its interactions with protein target(s). RESULTS: In this study, we successfully combined molecular fingerprint descriptors and gene descriptors (derived from gene ontology terms) to train deep neural networks that predict differential gene regulation endpoints collected in LINCS database. We achieved 10-fold cross-validation RAUC scores of and above 0.80, as well as enrichment factors of >5. We validated our models using an external RNA-Seq dataset generated in-house that described the effect of three potent antiandrogens (with different modes of action) on gene expression in LNCaP prostate cancer cell line. The results of this pilot study demonstrate that deep learning models can effectively synergize molecular and genomic descriptors and can be used to screen for novel drug candidates with the desired effect on gene expression. We anticipate that such models can find a broad use in developing novel cancer therapeutics and can facilitate precision oncology efforts. SUPPLEMENTARY INFORMATION: Supplementary data are available at Bioinformatics online. Godwin Woo, Michael Fernández, Michael Hsing, Nathan A. Lack, Ayse Derya Cavga, Artem Cherkasov |
Bioinform. | 2 |
| 2011 | Prediction of dinucleotide-specific RNA-binding sites in proteinsabstractBACKGROUND: Regulation of gene expression, protein synthesis, replication and assembly of many viruses involve RNA-protein interactions. Although some successful computational tools have been reported to recognize RNA binding sites in proteins, the problem of specificity remains poorly investigated. After the nucleotide base composition, the dinucleotide is the smallest unit of RNA sequence information and many RNA-binding proteins simply bind to regions enriched in one dinucleotide. Interaction preferences of protein subsequences and dinucleotides can be inferred from protein-RNA complex structures, enabling a training-based prediction approach. RESULTS: We analyzed basic statistics of amino acid-dinucleotide contacts in protein-RNA complexes and found their pairing preferences could be identified. Using a standard approach to represent protein subsequences by their evolutionary profile, we trained neural networks to predict multiclass target vectors corresponding to 16 possible contacting dinucleotide subsequences. In the cross-validation experiments, the accuracies of the optimum network, measured as areas under the curve (AUC) of the receiver operating characteristic (ROC) graphs, were in the range of 65-80%. CONCLUSIONS: Dinucleotide-specific contact predictions have also been extended to the prediction of interacting protein and RNA fragment pairs, which shows the applicability of this method to predict targets of RNA-binding proteins. A web server predicting the 16-dimensional contact probability matrix directly from a user-defined protein sequence was implemented and made available at: http://tardis.nibio.go.jp/netasa/srcpred. Michael Fernández, Yutaro Kumagai, Daron M. Standley, Akinori Sarai, Kenji Mizuguchi, Shandar Ahmad |
BMC Bioinform. | 1 |
| 2009 | Recognition of Drug-Target Interaction Patterns using Genetic Algorithm-optimized Bayesian-regularized Neural Networks and Support Vector MachinesabstractGenetic algorithm (GA) applied to feature selection and model optimization improved the performance of robust mathematical models such as Bayesian-regularized neural networks (BRANNs) and support vector machines (SVMs) on different drug design datasets. The selection of optimum input variables and the adjustment of network weights and biases to optimum values to yield generalizable predictors were optimized by combining Bayesian training and GA based-variable selection. Similarly, kernel and regularization parameters of SVMs were properly set by GA optimization. The predictors were more accurate and robust than previous published models on the same datasets. In addition, feature selection over large pools of molecular descriptors allowed determining the structural and atomic properties of the ligands that are ruling the biological interactions with the target. Michael Fernández, Akinori Sarai, Shandar Ahmad |
SMC | 1 |